This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hyer, M. L. Articles by Reed, J. C. Search for Related Content PubMed PubMed Citation Articles by Hyer, M. L. Articles by Reed, J. C.

Synthetic Triterpenoids Cooperate with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand to Induce Apoptosis of Breast Cancer Cells

¹ The Burnham Institute, La Jolla, California; ² Departments of Medicine and Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; ³ Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey; and ⁴ Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire

Requests for reprints: John C. Reed, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037. Phone: 858-646-3100; Fax: 858-646-3194; E-mail: jreed{at}burnham.org.

Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL or Apo2L) has been shown to induce apoptosis specifically in cancer cells while sparing normal tissues. Unfortunately not all cancer cells respond to TRAIL; therefore, TRAIL sensitizing agents are currently being explored. We have identified synthetic triterpenoids, including 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) and its derivative 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole (CDDO-Im), which sensitize TRAIL-resistant cancer cells to TRAIL-mediated apoptosis. Here we show that TRAIL-treated T47D and MDA-MB-468 breast cancer cells fail to initiate detectable caspase-8 processing and, consequently, do not initiate TRAIL-mediated apoptosis. Concomitant treatment with CDDO or CDDO-Im reverses the TRAIL-resistant phenotype, promoting robust caspase-8 processing and induction of TRAIL-mediated apoptosis in vitro. The combination of triterpenoids and monoclonal anti-TRAIL receptor-1 (DR4) antibody also induces apoptosis of breast cancer cells in vitro. From a mechanistic standpoint, we show that CDDO and CDDO-Im down-regulate the antiapoptotic protein c-FLIP_L, and up-regulate cell surface TRAIL receptors DR4 and DR5. CDDO and CDDO-Im, when used in combination with TRAIL, have no adverse affect on cultured normal human mammary epithelial cells. Moreover, CDDO-Im and TRAIL are well tolerated in mice and the combination of CDDO-Im and TRAIL reduces tumor burden in vivo in an MDA-MB-468 tumor xenograft model. These data suggest that CDDO and CDDO-Im may be useful for selectively reversing the TRAIL-resistant phenotype in cancer but not normal cells.

This article has been cited by other articles:

				B. Daroczi, G. Kari, Q. Ren, A. P. Dicker, and U. Rodeck Nuclear factor {kappa}B inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos Mol. Cancer Ther., September 1, 2009; 8(9): 2625 - 2634. [Abstract] [Full Text] [PDF]

				S. Yodkeeree, B. Sung, P. Limtrakul, and B. B. Aggarwal Zerumbone Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors in Human Colon Cancer Cells: Evidence for an Essential Role of Reactive Oxygen Species Cancer Res., August 15, 2009; 69(16): 6581 - 6589. [Abstract] [Full Text] [PDF]

				M. Krajewska, L. H. Smith, J. Rong, X. Huang, M. L. Hyer, N. Zeps, B. Iacopetta, S. P. Linke, A. H. Olson, J. C. Reed, et al. Image Analysis Algorithms for Immunohistochemical Assessment of Cell Death Events and Fibrosis in Tissue Sections J. Histochem. Cytochem., July 1, 2009; 57(7): 649 - 663. [Abstract] [Full Text] [PDF]

				S. Senthivinayagam, P. Mishra, S. K. Paramasivam, S. Yallapragada, M. Chatterjee, L. Wong, A. Rana, and B. Rana Caspase-mediated Cleavage of {beta}-Catenin Precedes Drug-induced Apoptosis in Resistant Cancer Cells J. Biol. Chem., May 15, 2009; 284(20): 13577 - 13588. [Abstract] [Full Text] [PDF]

				G. Gobbi, P. Mirandola, C. Carubbi, C. Micheloni, C. Malinverno, P. Lunghi, A. Bonati, and M. Vitale Phorbol ester-induced PKC{epsilon} down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation Blood, March 26, 2009; 113(13): 3080 - 3087. [Abstract] [Full Text] [PDF]

				A. Luce, A. Courtin, C. Levalois, S. Altmeyer-Morel, P.-H. Romeo, S. Chevillard, and J. Lebeau Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells Carcinogenesis, March 1, 2009; 30(3): 432 - 439. [Abstract] [Full Text] [PDF]

				M. Ganapathy, R. Ghosh, X. Jianping, X. Zhang, R. Bedolla, J. Schoolfield, I-T. Yeh, D. A. Troyer, A. F. Olumi, and A. P. Kumar Involvement of FLIP in 2-Methoxyestradiol-Induced Tumor Regression in Transgenic Adenocarcinoma of Mouse Prostate Model Clin. Cancer Res., March 1, 2009; 15(5): 1601 - 1611. [Abstract] [Full Text] [PDF]

				L. M. Knowles, C. Yang, A. Osterman, and J. W. Smith Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4 J. Biol. Chem., November 14, 2008; 283(46): 31378 - 31384. [Abstract] [Full Text] [PDF]

				R. Vene, P. Larghero, G. Arena, M. B. Sporn, A. Albini, and F. Tosetti Glycogen Synthase Kinase 3{beta} Regulates Cell Death Induced by Synthetic Triterpenoids Cancer Res., September 1, 2008; 68(17): 6987 - 6996. [Abstract] [Full Text] [PDF]

				K. Liby, R. Risingsong, D. B. Royce, C. R. Williams, M. M. Yore, T. Honda, G. W. Gribble, W. W. Lamph, N. Vannini, I. Sogno, et al. Prevention and Treatment of Experimental Estrogen Receptor-Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268 Clin. Cancer Res., July 15, 2008; 14(14): 4556 - 4563. [Abstract] [Full Text] [PDF]

				M. Lu, A. Strohecker, F. Chen, T. Kwan, J. Bosman, V. C. Jordan, and V. L. Cryns Aspirin Sensitizes Cancer Cells to TRAIL-Induced Apoptosis by Reducing Survivin Levels Clin. Cancer Res., May 15, 2008; 14(10): 3168 - 3176. [Abstract] [Full Text] [PDF]

				C. To, S. Kulkarni, T. Pawson, T. Honda, G. W. Gribble, M. B. Sporn, J. L. Wrana, and G. M. Di Guglielmo The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid-Imidazolide Alters Transforming Growth Factor {beta}-dependent Signaling and Cell Migration by Affecting the Cytoskeleton and the Polarity Complex J. Biol. Chem., April 25, 2008; 283(17): 11700 - 11713. [Abstract] [Full Text] [PDF]

				R. Ahmad, D. Raina, C. Meyer, and D. Kufe Triterpenoid CDDO-Methyl Ester Inhibits the Janus-Activated Kinase-1 (JAK1)->Signal Transducer and Activator of Transcription-3 (STAT3) Pathway by Direct Inhibition of JAK1 and STAT3 Cancer Res., April 15, 2008; 68(8): 2920 - 2926. [Abstract] [Full Text] [PDF]

				M. L. Hyer, R. Shi, M. Krajewska, C. Meyer, I. V. Lebedeva, P. B. Fisher, and J. C. Reed Apoptotic Activity and Mechanism of 2-Cyano-3,12-Dioxoolean-1,9-Dien-28-Oic-Acid and Related Synthetic Triterpenoids in Prostate Cancer Cancer Res., April 15, 2008; 68(8): 2927 - 2933. [Abstract] [Full Text] [PDF]

				F. Meslin, A. Hamai, P. Gao, A. Jalil, N. Cahuzac, S. Chouaib, and M. Mehrpour Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell Death Cancer Res., November 15, 2007; 67(22): 10910 - 10919. [Abstract] [Full Text] [PDF]

				S. Koschmieder, F. D'Alo, H. Radomska, C. Schoneich, J. S. Chang, M. Konopleva, S. Kobayashi, E. Levantini, N. Suh, A. Di Ruscio, et al. CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha Blood, November 15, 2007; 110(10): 3695 - 3705. [Abstract] [Full Text] [PDF]

				Y.-g. Son, E. H. Kim, J. Y. Kim, S. U. Kim, T. K. Kwon, A-R. Yoon, C.-O. Yun, and K. S. Choi Silibinin Sensitizes Human Glioma Cells to TRAIL-Mediated Apoptosis via DR5 Up-regulation and Down-regulation of c-FLIP and Survivin Cancer Res., September 1, 2007; 67(17): 8274 - 8284. [Abstract] [Full Text] [PDF]

				Y. Qiu, X. Liu, W. Zou, P. Yue, S. Lonial, F. R. Khuri, and S.-Y. Sun The Farnesyltransferase Inhibitor R115777 Up-regulates the Expression of Death Receptor 5 and Enhances TRAIL-Induced Apoptosis in Human Lung Cancer Cells Cancer Res., May 15, 2007; 67(10): 4973 - 4980. [Abstract] [Full Text] [PDF]

				U. Testa and R. Riccioni Deregulation of apoptosis in acute myeloid leukemia Haematologica, January 1, 2007; 92(1): 81 - 94. [Abstract] [Full Text] [PDF]

				M. M. Yore, K. T. Liby, T. Honda, G. W. Gribble, and M. B. Sporn The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-{kappa}B activation through direct inhibition of I{kappa}B kinase {beta} Mol. Cancer Ther., December 1, 2006; 5(12): 3232 - 3239. [Abstract] [Full Text] [PDF]

				R. Ahmad, D. Raina, C. Meyer, S. Kharbanda, and D. Kufe Triterpenoid CDDO-Me Blocks the NF-{kappa}B Pathway by Direct Inhibition of IKKbeta on Cys-179 J. Biol. Chem., November 24, 2006; 281(47): 35764 - 35769. [Abstract] [Full Text] [PDF]

				K. Liby, N. Voong, C. R. Williams, R. Risingsong, D. B. Royce, T. Honda, G. W. Gribble, M. B. Sporn, and J. J. Letterio The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells. Clin. Cancer Res., July 15, 2006; 12(14): 4288 - 4293. [Abstract] [Full Text] [PDF]

				A. Mookerjee, J. Mookerjee Basu, P. Dutta, S. Majumder, S. Bhattacharyya, J. Biswas, S. Pal, P. Mukherjee, S. Raha, R. N. Baral, et al. Overcoming Drug-Resistant Cancer by a Newly Developed Copper Chelate through Host-Protective Cytokine-Mediated Apoptosis. Clin. Cancer Res., July 15, 2006; 12(14): 4339 - 4349. [Abstract] [Full Text] [PDF]

				U. auf dem Keller, M. Huber, T. A. Beyer, A. Kumin, C. Siemes, S. Braun, P. Bugnon, V. Mitropoulos, D. A. Johnson, J. A. Johnson, et al. Nrf Transcription Factors in Keratinocytes Are Essential for Skin Tumor Prevention but Not for Wound Healing Mol. Cell. Biol., May 15, 2006; 26(10): 3773 - 3784. [Abstract] [Full Text] [PDF]

				A. Basu, V. P. Castle, M. Bouziane, K. Bhalla, and S. Haldar Crosstalk between Extrinsic and Intrinsic Cell Death Pathways in Pancreatic Cancer: Synergistic Action of Estrogen Metabolite and Ligands of Death Receptor Family. Cancer Res., April 15, 2006; 66(8): 4309 - 4318. [Abstract] [Full Text] [PDF]

				M. S. Ricci and W.-X. Zong Chemotherapeutic approaches for targeting cell death pathways. Oncologist, April 1, 2006; 11(4): 342 - 357. [Abstract] [Full Text] [PDF]